EG22337A - Process for preparing novel pharmaceutical compounds - Google Patents

Process for preparing novel pharmaceutical compounds

Info

Publication number
EG22337A
EG22337A EG155698A EG155698A EG22337A EG 22337 A EG22337 A EG 22337A EG 155698 A EG155698 A EG 155698A EG 155698 A EG155698 A EG 155698A EG 22337 A EG22337 A EG 22337A
Authority
EG
Egypt
Prior art keywords
pharmaceutical compounds
novel pharmaceutical
preparing novel
preparing
compounds
Prior art date
Application number
EG155698A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of EG22337A publication Critical patent/EG22337A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG155698A 1997-12-16 1998-12-15 Process for preparing novel pharmaceutical compounds EG22337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726566.4A GB9726566D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
EG22337A true EG22337A (en) 2002-12-31

Family

ID=10823692

Family Applications (1)

Application Number Title Priority Date Filing Date
EG155698A EG22337A (en) 1997-12-16 1998-12-15 Process for preparing novel pharmaceutical compounds

Country Status (35)

Country Link
EP (2) EP1661895A1 (cs)
JP (1) JP2002508373A (cs)
KR (1) KR100549142B1 (cs)
CN (3) CN101302215A (cs)
AP (1) AP1365A (cs)
AR (1) AR017214A1 (cs)
AU (1) AU1967999A (cs)
BG (1) BG64988B1 (cs)
BR (1) BR9813600A (cs)
CA (1) CA2314107A1 (cs)
CO (1) CO4980880A1 (cs)
CZ (1) CZ299965B6 (cs)
DZ (1) DZ2681A1 (cs)
EA (1) EA004260B1 (cs)
EG (1) EG22337A (cs)
GB (1) GB9726566D0 (cs)
HR (1) HRP20000408B1 (cs)
HU (1) HUP0100509A3 (cs)
IL (1) IL136424A (cs)
IN (1) IN192487B (cs)
MA (1) MA26580A1 (cs)
MY (1) MY135612A (cs)
NO (1) NO317254B1 (cs)
OA (1) OA11766A (cs)
PE (1) PE20000058A1 (cs)
PL (1) PL341146A1 (cs)
RS (1) RS50126B (cs)
SA (1) SA99191115B1 (cs)
SK (1) SK286618B6 (cs)
TR (2) TR200001799T2 (cs)
TW (1) TW509690B (cs)
UA (1) UA72198C2 (cs)
UY (2) UY25308A1 (cs)
WO (1) WO1999031095A1 (cs)
ZA (1) ZA9811506B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
JP2002543075A (ja) * 1999-04-23 2002-12-17 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
CA2370262A1 (en) * 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
PL365533A1 (en) 2000-04-25 2005-01-10 Kyorin Pharmaceutical Co, Ltd. Novel stable crystal of thiazolidinedione derivative and process for producing the same
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
KR20030082541A (ko) * 2000-09-26 2003-10-22 닥터 레디스 레보러터리즈 리미티드 5-[4-[2-[엔-메틸-엔-(2-피리딜)아미노]에톡시]벤질]티아졸리딘 4-디온 말레이트의 신규의 다형상 및 그제조방법
HUP0301161A3 (en) * 2000-09-26 2005-04-28 Reddy S Res Foundation Hyderab Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate and process for their preparation
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
CA2182986A1 (en) * 1994-02-10 1995-08-17 Smithkline Beecham P.L.C. Use of insulin sensitisers for treating renal diseases

Also Published As

Publication number Publication date
JP2002508373A (ja) 2002-03-19
DZ2681A1 (fr) 2004-06-20
KR20010033141A (ko) 2001-04-25
ZA9811506B (en) 2000-11-06
IL136424A0 (en) 2001-06-14
EA200000654A1 (ru) 2000-12-25
TW509690B (en) 2002-11-11
UY25308A1 (es) 1999-07-19
UY25304A1 (es) 2000-12-29
MY135612A (en) 2008-05-30
SK9172000A3 (en) 2001-01-18
GB9726566D0 (en) 1998-02-11
TR200001799T2 (tr) 2001-01-22
OA11766A (en) 2005-07-19
BG104603A (en) 2001-03-30
NO20003069L (no) 2000-06-15
UA72198C2 (en) 2005-02-15
CN1281453A (zh) 2001-01-24
TR199802625A2 (xx) 1999-10-21
YU36300A (sh) 2004-03-12
HRP20000408A2 (en) 2000-08-31
AP2000001831A0 (en) 2000-06-30
AP1365A (en) 2005-01-26
EA004260B1 (ru) 2004-02-26
BR9813600A (pt) 2000-10-10
HUP0100509A3 (en) 2002-06-28
NO20003069D0 (no) 2000-06-15
TR199802625A3 (tr) 1999-10-21
NO317254B1 (no) 2004-09-27
IL136424A (en) 2003-12-10
SK286618B6 (sk) 2009-02-05
HUP0100509A2 (hu) 2002-05-29
EP1661895A1 (en) 2006-05-31
HRP20000408B1 (hr) 2008-04-30
SA99191115B1 (ar) 2006-10-11
CZ299965B6 (cs) 2009-01-07
KR100549142B1 (ko) 2006-02-03
CZ20002204A3 (cs) 2000-11-15
CN101381367A (zh) 2009-03-11
MA26580A1 (fr) 2004-12-20
WO1999031095A1 (en) 1999-06-24
CN101302215A (zh) 2008-11-12
BG64988B1 (bg) 2006-11-30
RS50126B (sr) 2009-03-25
CA2314107A1 (en) 1999-06-24
PL341146A1 (en) 2001-03-26
PE20000058A1 (es) 2000-02-26
AU1967999A (en) 1999-07-05
EP1040110A1 (en) 2000-10-04
IN192487B (cs) 2004-04-24
CO4980880A1 (es) 2000-11-27
AR017214A1 (es) 2001-08-22

Similar Documents

Publication Publication Date Title
EG22337A (en) Process for preparing novel pharmaceutical compounds
CY2551B1 (en) Process for preparing eprosartan
CY2555B1 (en) Process for preparing eprosartan
HU9802180D0 (en) Process for producing pharmaceutical compositions
EP1026255A4 (en) PROCESS FOR THE PREPARATION OF XYLITOL
SG70092A1 (en) Process for preparing dialkylnaphthalene
IL133140A0 (en) Novel process for the preparation of 4-aryl-piperidines
IL134059A0 (en) Process for preparing aminoarylacetylenes
IL131205A0 (en) Process for preparing pharmaceutical compounds
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1026254A4 (en) METHOD FOR PRODUCING XYLITOL
IL126184A (en) Process for preparing pentafluoropentanol
AU7697298A (en) Process for preparing heterocyclic compounds
AU4233997A (en) Process for preparing pharmaceutical compounds
EG21226A (en) Process for preparing of new pharmaceutical compound
IL133288A (en) Process for preparing 3-isochromanone
GB9810502D0 (en) Process for preparing distrylbiphenyl compounds
EP0694512A3 (de) Verfahren zur Herstellung von Hexafluor-C4-Verbindungen
HU9701137D0 (en) Process for producing pharmaceutical intermedier
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
GB9800066D0 (en) Process for preparing dibenzocycycloheptene compounds
AU8232098A (en) Process for preparing tri-aryl-alkylalkenes
AU7667598A (en) Process for preparing 3-isochromanome
IL128643A0 (en) Process to prepare pharmaceutical compounds
IL130950A (en) Process for preparing carboxamido-4-azasteroids